Cite
HARVARD Citation
Higuchi, T. et al. (2019). Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model. Cancer letters. pp. 122-127. [Online].